Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on: March 01,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on:March 01,2024

Critical Review of the Role of Exosomal miR-519a-3p in Gastric Cancer Liver Metastasis through M2 Macrophage Polarization

Updated on: October 04,2024

Critical Review of the Role of Exosomal miR-519a-3p in Gastric Cancer Liver Metastasis through M2 Macrophage Polarization

Updated on:October 04,2024

Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on: December 28,2023

Quality of treatment for lung cancer varies widely across US

byWashington University in St. LouisA new study by researchers at Washington University School of Medicine in St. Louis found that the quality of care for lung cancer in the U.S. varies widely.

Updated on:December 28,2023

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on: March 20,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on:March 20,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on: March 14,2024

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

by Jeff Hansen,University of Alabama at BirminghamLudwine Messiaen, Ph.D., left, and Magdalena Koczkowska, Ph.D. Credit: University of Alabama at BirminghamInternational collaborative research l

Updated on:March 14,2024

Consumer health: Understanding metastatic brain cancer

by Laurel KellyCredit: Unsplash/CC0 Public DomainMay is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer.Overall, the chance that a person will develop

Updated on: January 11,2024

Consumer health: Understanding metastatic brain cancer

by Laurel KellyCredit: Unsplash/CC0 Public DomainMay is Brain Cancer Awareness Month, which makes this a good time to learn about metastatic brain cancer.Overall, the chance that a person will develop

Updated on:January 11,2024

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on: May 20,2024

Radiation after surgery triples survival for a type of pediatric brain tumor

by St. Jude Children's Research HospitalPrincipal investigator Thomas Merchant, D.O. Ph.D., consults with an ependymoma patient at St. Jude. Credit: Seth Dixon / St. Jude Children's Resea

Updated on:May 20,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on: January 30,2024

Researchers discover potential new melanoma treatment, giving hope to patients

by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t

Updated on:January 30,2024